Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCorewell Health East

About this trial

This is a prospective, parallel, non-blinded, two-arm randomized controlled trial of intravenous catheter failure evaluating the impact of a built-in guide wire. The objective of this study is to demonstrate that the control ultralong intravenous catheter (IV) without the guide wire is non-inferior to the experimental catheter with the guide wire. After obtaining consent, eligible patients will be randomly allocated to control Arm 1 (ultralong intravenous catheter) or experimental Arm 2 (ultralong intravenous catheter with guide wire) in a ratio of 1:1 via a computer-generated randomization schedule. The participants will be followed to collect data until the catheter is removed.

Eligibility criteria

Qualifiers

Visible with distention and easily palpable

Visible and easily palpable

Not visible and easily palpable

Visible and poorly palpable

Disqualifiers

None

Trial design

Treatments tested in this trial

  • B. Braun 6.35cm 20 gauge ultralong intravenous catheter
  • BD 5.71 cm 20 gauge Accucath

Treatment groups

360 Participants
are divided into 2 treatment groups

Sponsors and collaborators